Select Bibliography

Filter by any of these (after searching):

Dercle, Laurent

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 4 items

Enhancing Drug Development for Neuroendocrine Tumors: A novel radiomic signature to predict survival in patients enrolled in Alliance A021202

Dercle, Laurent , Geyer, Susan M. , Asmis, Timothy R. ... - NETRF - - 2023

Abstract - Secondary - Primary - GI - Alliance-A021202

Radiomic signatures to predict survival in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib +/- doxorubicin: Correlative Science from CALGB 80802

Dercle, Laurent , Geyer, Susan , Nixon, Andrew , Innocenti, Federico ... - ASCO GI - J Clin Oncol - 2021

Abstract - Secondary-not-in-original - Primary - GI - CALGB-80802

MAIN-CAV: Phase III randomized trial of maintenance cabozantinib (CABO) and avelumab versus Avelumab after first-line platinum-based chemotherapy in patients with metastatic urothelial cancer (mUC) (Alliance A032001).

Gupta, Shilpa , Galsky, Matthew D. , Morris, Michael J. ... - ASCO - J Clin Oncol - 2022

Abstract - No-Endpoint - Trial-Description-Only - GU - Alliance-A032001

Gupta, Shilpa , Galsky, Matthew D. , Morris, Michael J. ... - ASCO GU - J Clin Oncol - 2024

Abstract - No-Endpoint - Trial-Description-Only - GU - Alliance-A032001